20 May 2013
Keywords: xenical, recommended, approval, cpmp, roche, revealed, its
Article | 16 April 1998
Roche revealed at its annual press update on April 7 that its newpancreatic lipase inhibitor Xenical (orlistat), widely-tipped as a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 April 1998
© 2013 thepharmaletter.com